Related Experiment Video
Updated: May 3, 2026

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
Cardiopulmonary bypass in a pediatric patient with factor XII deficiency
Julie M Fenske1, Julie Tinius Juliani1, Cynthia Herrington1
1Children's Hospital Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA.
Abstract:
The safe use of cardiopulmonary bypass (CPB) relies upon the ability to administer, monitor, and reverse anticoagulation. Although rare, the factor XII deficient patient creates a challenge for the perfusionist due to resultant complications in monitoring anticoagulation. There have been proposed strategies to aid in monitoring anticoagulation in factor XII deficient patients, however, documentation of successful monitoring during CPB is infrequent. With the use of the Hemochron Signature Elite and ACT + cartridges, CPB in a factor XII deficient 8-month-old was completed with predictable and reliable anticoagulation monitoring. This case report explores the current suggestions for factor XII deficiency management with CPB.

